Emma Irwin advises clients on complex cross-border intellectual property litigation disputes, particularly in patent litigation cases. Having litigated several innovative technologies before the Court of England & Wales and coordinated litigation strategy in more than 20 countries, Ms. Irwin brings strong focus in ensuring that clients benefit from consistent, convincing and case-wining narratives before national courts and patent offices.  

Ms. Irwin’s passion for science and background in biochemistry is a particular asset for clients in her life sciences work, where she uses her interest and understanding of the technical aspects of work to identify game-changing litigation opportunities. She has been involved in litigation concerning technology ranging from small molecule, formulation, dosage regimen and monoclonal antibodies to consumer electronics. Alongside her contentious practice, she is experienced in advisory work, particularly in the preparation of freedom to operate advice, regulatory and contractual issues at the interface of IP. 


  • Education

    • Postgraduate Diploma, Intellectual Property Law and Practice, University of Oxford, 2019

    • Legal Practice Course, BPP University, 2016

    • Graduate Diploma, Law, BPP University, 2015

    • BSc, Biochemistry, University of Bristol, 2014

  • Admissions

    • Solicitor, England and Wales



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.